Benign oesophageal strictures are an important gastrointestinal condition that can cause substantial morbidity. There are many different aetiologies and each case needs careful evaluation and individualised treatment. Management usually involves targeting therapy to the underlying cause, but oesophageal dilatation is an important part of the algorithm. The recent British Society of Gastroenterology guidelines provide advice on the use of dilatation for benign strictures and cover patient preparation, the dilatation procedure and disease-specific considerations. This article provides a summary of the key messages from the guidelines and applies them to routine clinical practice. It also includes practical advice on the clinical assessment, investigation and management of benign oesophageal strictures and gives an approach to the management of refractory strictures. Areas where evidence is sparse and further research is needed are highlighted.
- oesophageal strictures
- therapeutic endoscopy
- gastroesophageal reflux disease
Statistics from Altmetric.com
Patient consent for publication Not required.
Contributors NEB and SE drafted and approved the manuscript.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests SE has received honoraria from Olympus/Keymed and sponsorship from FALK to attend international meetings.
Provenance and peer review Commissioned; externally peer reviewed.
Correction notice This article has been corrected since it published Online First. The second sentence in ’The guidelines in clinical practice' section has been corrected and the provenance and peer review statement has been corrected to Commissioned.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.